Konjac Glucomannan-Assisted Curcumin Alleviated Dextran Sulfate Sodium-Induced Mice Colitis Via Regulating Immune Response and Maintaining Intestinal Barrier Integrity.

Pengkui Xia,Mengge Zhao,Hong Jin,Tao Hou,Zhichang Deng,Mengting Zhang,Qiaoyun Zhou,Fuchao Zhan,Bin Li,Jing Li
DOI: https://doi.org/10.1039/d3fo01068f
IF: 6.3173
2023-01-01
Food & Function
Abstract:Curcumin has been proven to be an effective strategy for reducing inflammatory responses. However, low bioavailability and instability at the physiological pH have limited its anti-inflammatory activity in ulcerative colitis patients. In the present study, a complex of curcumin and konjac glucomannan (KGM) effectively inhibited intestinal inflammation and this effect was associated with KGM degradation degrees. Results demonstrated that treatment with the complex markedly mitigated colitis symptoms and decreased inflammatory cytokines levels, especially in the complex treatment groups with K110 (KGM treated in 110 °C) and konjac oligosaccharides (KOSs). Furthermore, increasing the KOS content in KOC (the complex of curcumin and KOS) promoted the gene expressions of the intestinal barrier and inhibited the gene expressions of inflammatory cytokines, as well as improved gut microbiota dysregulation. Overall, our studies suggest that the complex of curcumin and KGM exerts effective anti-inflammatory effects by regulating the intestinal immune response and modulating microbiota diversity and composition.
What problem does this paper attempt to address?